Targeted Therapy and Immunotherapy for Melanoma in Japan

por Namikawa, Kenjiro, Yamazaki, Naoya
Publicado en Curr Treat Options Oncol (2019)

Intramedullary spinal cord metastasis of malignant melanoma:Two cases with rim signs in contrast-enhanced magnetic resonance imaging: A case report

por Mizuta, Haruki, Namikawa, Kenjiro, Nakama, Kenta, Yamazaki, Naoya
Publicado en Mol Clin Oncol (2021)

Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for...

por Namikawa, Kenjiro, Aung, Phyu P., Gershenwald, Jeffrey E., Milton, Denái R., Prieto, Victor G.
Publicado en Cancer Med (2018)

Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation‐positive advanced cutaneous melanoma...

por Yamazaki, Naoya, Tsutsumida, Arata, Takahashi, Akira, Namikawa, Kenjiro, Yoshikawa, Shusuke, Fujiwara, Yutaka, Kondo, Shunsuke, Mukaiyama, Akihira, Zhang, Fanghong, Kiyohara, Yoshio
Publicado en J Dermatol (2018)

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protoco...

por Oashi, Kohei, Shibata, Taro, Namikawa, Kenjiro, Takahashi, Akira, Yokota, Kenji, Nakano, Eiji, Teramoto, Yukiko, Tsutsumida, Arata, Maeda, Taku, Yamazaki, Naoya
Publicado en BMC Cancer (2020)

Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study)

por Yamazaki, Naoya, Takenouchi, Tatsuya, Nakamura, Yasuhiro, Takahashi, Akira, Namikawa, Kenjiro, Kitano, Shigehisa, Fujita, Tomonobu, Kubota, Kazumi, Yamanaka, Takeharu, Kawakami, Yutaka
Publicado en Jpn J Clin Oncol (2021)

BRAF V600 mutations and pathological features in Japanese melanoma patients

por Yamazaki, Naoya, Tanaka, Ryota, Tsutsumida, Arata, Namikawa, Kenjiro, Eguchi, Hironobu, Omata, Wataru, Oashi, Kohei, Ogawa, Toru, Hayashi, Amiko, Nakamura, Noriyuki, Tsuta, Koji
Publicado en Melanoma Res (2015)

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

por Nakamura, Yoshio, Kitano, Shigehisa, Takahashi, Akira, Tsutsumida, Arata, Namikawa, Kenjiro, Tanese, Keiji, Abe, Takayuki, Funakoshi, Takeru, Yamamoto, Noboru, Amagai, Masayuki, Yamazaki, Naoya
Publicado en Oncotarget (2016)

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1...

por Namikawa, Kenjiro, Tsutsumida, Arata, Mizutani, Tomonori, Shibata, Taro, Takenouchi, Tatsuya, Yoshikawa, Shusuke, Kiyohara, Yoshio, Uchi, Hiroshi, Furue, Masutaka, Ogata, Dai, Tsuchida, Tetsuya, Yamazaki, Naoya
Publicado en Jpn J Clin Oncol (2017)

Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol)

por Tanaka, Kiyo, Nakamura, Yasuhiro, Mizutani, Tomonori, Shibata, Taro, Tsutsumida, Arata, Fukuda, Haruhiko, Matsushita, Shigeto, Aoki, Megumi, Namikawa, Kenjiro, Ohe, Shuichi, Fukushima, Satoshi, Yamazaki, Naoya
Publicado en BMC Cancer (2019)

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)(V600E) Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis

por Yokomichi, Hiroshi, Inozume, Takashi, Wada, Makoto, Asai, Jun, Igaki, Hiroshi, Namikawa, Kenjiro, Hayashi, Ayato, Fukushima, Satoshi, Fujimura, Taku, Koga, Hiroshi, Nakamura, Yasuhiro, Mochizuki, Mie, Yamagata, Zentaro
Publicado en JMA J (2020)

Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma

por Namikawa, Kenjiro, Kiyohara, Yoshio, Takenouchi, Tatsuya, Uhara, Hisashi, Uchi, Hiroshi, Yoshikawa, Shusuke, Takatsuka, Sumiko, Koga, Hiroshi, Wada, Naoko, Minami, Hironobu, Hatsumichi, Masahiro, Namba, Yoshinobu, Yamazaki, Naoya
Publicado en J Dermatol (2020)

Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)

por Ishii, Maki, Hirai, Ikuko, Tanese, Keiji, Fusumae, Takayuki, Nakamura, Yoshio, Fukuda, Keitaro, Uchi, Hiroshi, Kabashima, Kenji, Otsuka, Atsushi, Yokota, Kenji, Yamazaki, Naoya, Namikawa, Kenjiro, Fujimura, Taku, Takenouchi, Tatsuya, Yamamoto, Yuki, Nishiguchi, Mana, Sato, Yasunori, Amagai, Masayuki, Funakoshi, Takeru
Publicado en Medicine (Baltimore) (2020)

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

por Fujisawa, Yasuhiro, Yoshikawa, Shusuke, Minagawa, Akane, Takenouchi, Tatsuya, Yokota, Kenji, Uchi, Hiroshi, Noma, Naoki, Nakamura, Yasuhiro, Asai, Jun, Kato, Junji, Fujiwara, Susumu, Fukushima, Satoshi, Uehara, Jiro, Hoashi, Toshihiko, Kaji, Tatsuya, Fujimura, Taku, Namikawa, Kenjiro, Yoshioka, Manabu, Murao, Naoki, Ogata, Dai, Matsuyama, Kanako, Hatta, Naohito, Shibayama, Yoshitsugu, Fujiyama, Toshiharu, Ishikawa, Masashi, Yamada, Daisuke, Kishi, Akiko, Nakamura, Yoshiyuki, Shimiauchi, Takatoshi, Fujii, Kazuyasu, Fujimoto, Manabu, Ihn, Hironobu, Katoh, Norito
Publicado en Cancer Med (2019)